Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas

NCT02048488 is registered in ClinicalTrials.gov with Tesaro, Inc. as lead sponsor.

NCT NCT02048488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02048488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas
Lead sponsor
Tesaro, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2012
Completion date
June 30, 2018
Enrollment
72 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

lymphomas, solid tumors